Holdings
Royalty Pharma Sub-Manager, LLC
As of Sep 30, 2026, Royalty Pharma Sub-Manager, LLC reported 4 positions worth US$196M. Largest: Cytokinetics, Incorporated, Zenas BioPharma, Inc. and Biohaven Ltd. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cytokinetics, Incorporated | 980K | US$64.6M | no change | Sep 30, 2026 |
| Zenas BioPharma, Inc. | 2.39M | US$64.4M | no change | Sep 30, 2026 |
| Biohaven Ltd. | 2.94M | US$39.2M | no change | Sep 30, 2026 |
| Kailera Therapeutics, Inc. | 2.46M | US$28M | no change | Sep 30, 2026 |